Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03830086Completed
Randomised, open-label trial of bupivacaine in pain (2 arms), sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoint: Feasibility and safety: Clavien-Dindo Classification at 7 days. Started Feb 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03830086.